RxDoctor Payments Data

Margaret Riso, MD

Pain Medicine · Gainesville, GANPI 1417337320

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (52.5%), travel and lodging and education — rather than concentrated in one kind of arrangement. 21 manufacturers reported payments, led by Abbott at 34.8% of the total. Reporting peaked in 2024 at $12,093 and has fallen 69.2% since, to $3,725 in 2025. Among pain medicine clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$19,132in general payments, 2019–2025

Across 205 payments — averaging $93.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$7K
  • Medtronic$4K
  • Saluda Medical Americas, Inc.$3K
  • Boston Scientific$2K
  • Nevro Corp.$1K
  • Biotronik NRO, Inc.$601
  • plus $2K from 15 others

What the payments were for

  • Travel & lodging$9,07547%
  • Food & beverage$10,04452%
  • Education$130%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$19,132 in reported general payments places this provider in the 95th percentile of 203 pain medicine providers in Georgia.

See all pain medicine providers in Georgia

Medicare billing

Part B allowed, 2024
$121,288
Medicare patients
161
Services billed
1,242

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Xtampza ErOxycodone Myristate19$12,509
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen361$8,772
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen282$7,158
Oxycodone Hcl154$2,941
Pregabalin66$1,181
Gabapentin101$1,118
Tizanidine Hcl80$979
Morphine Sulfate ErMorphine Sulfate27$838
Methocarbamol33$627
Tramadol Hcl31$380
Diclofenac Sodium21$335
Baclofen30$327
Duloxetine Hcl32$309
Cyclobenzaprine Hcl29$235
Nortriptyline Hcl17$204

Paid to pharmacies, not to this prescriber.

Other pain medicine in Gainesville

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →